PRTODAY / NewswireToday Free press release distribution service network

Written by / Agency / Source: The Scott Partnership

Check Ads Availability|e-mail Article

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Novozymes Biopharma Unveils New Online Customer Experience - Novozymes Biopharma, part of Novozymes A/S, world leader in bio-innovation, today unveils its new website
Novozymes Biopharma Unveils New Online Customer Experience


NewswireToday - /newswire/ - Holmes Chapel, Cheshire, United Kingdom, 2009/08/18 - Novozymes Biopharma, part of Novozymes A/S, world leader in bio-innovation, today unveils its new website.

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


The new website has been designed to enhance usability and provide a comprehensive resource for information on Novozymes Biopharma's innovative range of products and technologies. Novozymes Biopharma specializes in recombinant products and technologies for the biopharmaceutical industry helping customers improve drug safety and efficacy.

Building on its established pedigree and reputation in the pharmaceutical and biotechnology industries, the new easy to navigate website provides visitors with quick and easy access to a wealth of information about customer solutions to optimize biopharmaceutical manufacturing, improve drug products and contribute to better lives for patients. The site incorporates the latest company news and events, and in-depth resource sections offering downloadable brochures, application notes and data sheets on all Novozymes Biopharma's animal-free products and technologies. Visitors can also use the website to view specialist articles and presentations from key company representatives covering a number of interesting industry topics.

Novozymes Biopharma is committed to creating an open dialog and developing lasting partnerships throughout the biopharmaceutical industry. To reflect this, the new website has enhanced its customer interaction facilities and allows customers to request meetings and product samples. Further information can also be requested on any product or application at the touch of a button.

Visitors to the new website have the opportunity to win an Apple MacBook Air during the first month of the launch. By completing a two minute online entry form participants will be entered into this special prize draw and the winner will be notified by email.

Peter Rosholm, Vice President at Novozymes Biopharma, said: "We are delighted to announce the launch of our new website. Novozymes is committed to keeping its customers ahead of industry challenges and developing tailored solutions to deliver continued commercial success. This new website provides a comprehensive resource for both current customers and organizations interested in how Novozymes' animal-free solutions can significantly improve efficiency."

Apple MacBook Air is a trademark of Apple, Inc.

About Novozymes
Novozymes ( is the world leader in bioinnovation. Together with customers across a broad array of industries, we create tomorrow's industrial biosolutions, improving our customers' business and the use of our planet's resources.

With over 700 products used in 130 countries, Novozymes' bioinnovations improve industrial performance and safeguard the world's resources by offering superior and sustainable solutions for tomorrow's ever-changing marketplace.

Novozymes' natural solutions enhance and promote everything from removing trans-fats in food, to advancing biofuels to power the world tomorrow. Our never-ending exploration of nature's potential is evidenced by over 6,000 patents, showing what is possible when nature and technology join forces.

Our 5,000+ employees working in research, production and sales around the world are committed to shaping business today and our world tomorrow.

Novozymes Biopharma:
Sally Vernon, Marketing Communications Manager
T: +44 115 955 3355
E: syke[.]

Corporate Contacts:
Press and media:
Johan Melchior
T: +45 4446 0690
M: +45 3077 0690
René Tronborg
T: +45 4446 2274
M: +45 3077 2274
Paige Donnelly (USA)
T: +1 919 494 3209
M: +1 919 218 4501

Investor relations:
Camilla Kinch Jensen
T: +45 4446 0852
M: +45 3077 0852
Tobias Bjørklund (USA)
T: +1 919 494 3483
M: +1 919 649 2565

Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


Written by / Agency / Source: The Scott Partnership


Availability: All Regions (Including Int'l)


Traffic Booster: [/] Quick Newswire Today Visibility Checker


Distribution / Indexing: [+]

# # #

  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!

Novozymes Biopharma Unveils New Online Customer Experience

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name Newswire Today and LINK as the source.
  Is this your article?
Activate ALL web links and social stream by Upgrading to Press Release PREMIUM Plan Now!

Publisher Contact: Fiona Robinson 
+44 1477 539539 pr[.]
Newswire Today - PRZOOM / PRTODAY disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any The Scott Partnership securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY

Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!

Read Latest Articles From The Scott Partnership / Company Profile

Read Pharma/BioTech/Nutrition Most Recent Related Newswires:

U.S. FDA Approves New Indication for Ipsen’s Somatuline® Depot (lanreotide) Injection for the Treatment of Carcinoid Syndrome
Genentech Provides Update on First Lampalizumab Phase III Study for Geographic Atrophy, an Advanced Form of Age-Related Macular Degeneration
mProve Health and Greenphire Partner to Deliver a First-of-its-Kind Patient Engagement Solution
FDA Approves Genentech’s Actemra (Tocilizumab) for the Treatment of CAR T Cell-Induced Cytokine Release Syndrome
Greenphire Named to Inc. 5000 for Fifth Consecutive Year
Five Community Health Centers Honored for Innovative Approaches to Medication Therapy Management
FDA Grants Priority Review for Genentech’s Gazyva in Previously Untreated Follicular Lymphoma
ProSci Incorporates Flow Cytometry Screening to Custom Monoclonal Antibody Service
FDA Grants Priority Review to Genentech's Emicizumab for Hemophilia A with Inhibitors
BD Expands Suite of Blood Culture Offerings with New BD BACTEC™ Standard Aerobic & Standard Anaerobic Plastic Bottles
Twist Bioscience Collaborates with Synbio Technologies to Supply Long DNA to Customers
FDA Grants Priority Review and Breakthrough Therapy Designation for Zelboraf (vemurafenib) in Erdheim-Chester Disease with BRAF V600 Mutation
Ipsen Receives Positive CHMP Opinion for Approval of Xermelo® (telotristat Ethyl)
BD Receives FDA 510(k) Clearance for New Immunological Diagnostic System
Positive Phase III Results for Genentech’s Emicizumab in Hemophilia A Published in The New England Journal of Medicine

Boost Your Social Network
& Crowdfunding Campaigns

NewswireToday Celebrates 10 Years in Business


Visit  RightITnow Ltd


  ©2017 Newswire Today — Limelon Advertising, Co.
Home | About | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneurs newswire distribution freenewswiredistribution asianewstoday bizwiretoday USA pr UK today - NOT affiliated with PRNewswire as we declined their partnership offer in 2013
PRTODAY & NewswireTODAY are NOT affiliated with USA TODAY (